Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23)

Samantha Scaramuzza, Luca Biasco, A. Ripamonti, Maria Carmina Castiello, Mariana Loperfido, Elena Draghici, Raisa Jofra Hernandez, Fabrizio Benedicenti, Marina Radrizzani, Monica Salomoni, Marco Ranzani, Cynthia Bartholomae, Elisa Vicenzi, Andrea Finocchi, Robbert G M Bredius, Marita Bosticardo, Manfred Schmidt, Christof Von Kalle, Eugenio Montini, Alessandra BiffiMaria Grazia Roncarolo, Luigi Naldini, Anna Villa, Alessandro Aiuti

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1159
Number of pages1
JournalMolecular Therapy
Volume24
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Genetics
  • Drug Discovery
  • Pharmacology

Cite this

Scaramuzza, S., Biasco, L., Ripamonti, A., Castiello, M. C., Loperfido, M., Draghici, E., Hernandez, R. J., Benedicenti, F., Radrizzani, M., Salomoni, M., Ranzani, M., Bartholomae, C., Vicenzi, E., Finocchi, A., Bredius, R. G. M., Bosticardo, M., Schmidt, M., Von Kalle, C., Montini, E., ... Aiuti, A. (2016). Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23). Molecular Therapy, 24(6), 1159. https://doi.org/10.1038/mt.2016.96